SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
cas12216-sup-0001-FigureS1-S4.pdfapplication/PDF2831K

Fig. S1. Representative dot plot analyses of PBMCs in each group.

Fig. S2. Patients with CML taking imatinib (IM) showed low PBMC counts.

Fig. S3. Immunophenotypic profiles of natural killer (NK) cells in cell counts.

Fig. S4. Immunophenotypic profiles of CD8+ T cells in cell counts.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.